Hologic Secures All Regulatory Approvals for Go-Private Merger, CEO MacMillan to Retire Upon Close

summarizeSummary

Hologic announced it has received all necessary regulatory approvals for its go-private acquisition by Blackstone and TPG, with the transaction expected to close on April 7, 2026. CEO Stephen P. MacMillan will retire upon the merger's completion.

check_boxKey Events

• Merger Regulatory Approvals Complete

  Hologic has received all necessary regulatory approvals for its acquisition by affiliates of funds managed by Blackstone Inc. and TPG Global, LLC.

• Go-Private Transaction Imminent

  The acquisition is now expected to close on or about April 7, 2026, finalizing the company's transition to private ownership, following the merger terms confirmed on 2026-01-12.

• CEO Stephen MacMillan to Retire

  Stephen P. MacMillan will retire as President, CEO, and Chairman of the Board, effective immediately after the closing of the merger.

auto_awesomeAnalysis

This filing marks the definitive conclusion of Hologic's go-private acquisition, a major corporate event that fundamentally alters the company's future as a publicly traded entity. The receipt of all regulatory approvals and the imminent closing date remove all remaining uncertainty for shareholders regarding the transaction. The retirement of long-time CEO Stephen P. MacMillan is a direct consequence of this acquisition, signaling a leadership transition as the company moves into private ownership. This news provides finality to the merger process, which had previously faced challenges including lawsuits, as noted in the Q1 2026 financial baseline.